Klughammer, J., Kiesel, B., Roetzer, T., Fortelny, N., Nemc, A., Nenning, K.-H., Furtner, J., Sheffield, N.C., Datlinger, P., Peter, N., Nowosielski, M., Augustin, M., Mischkulnig, M., Ströbel, T., Alpar, D., Ergüner, B., Senekowitsch, M., Moser, P., Freyschlag, C.F., Kerschbaumer, J., Thomé, C., Grams, A.E., Stockhammer, G., Kitzwogerer, M., Oberndorfer, S., Marhold, F., Weis, S., Trenkler, J., Buchroithner, J., Pichler, J., Haybaeck, J., Krassnig, S., Ali, K.Mahdy, von Campe, G., Payer, F., Sherif, C., Preiser, J., Hauser, T., Winkler, P.A., Kleindienst, W., Würtz, F., Brandner-Kokalj, T., Stultschnig, M., Schweiger, S., Dieckmann, K., Preusser, M., Langs, G., Baumann, B., Knosp, E., Widhalm, G., Marosi, C., Hainfellner, J.A., Woehrer, A. & Bock, C., 2018. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nature Medicine, 24, S.1611-1624.
